Organon & Co.OGN
Market cap
$1.9B
P/E ratio
| Dec 31, 2021 | Dec 31, 2022 | Dec 31, 2023 | Dec 31, 2024 | |
| Revenues | 6,304 | 6,174 | 6,263 | 6,403 |
| Cost of sales | 2,382 | 2,294 | 2,515 | 2,688 |
| Gross profit | - | - | - | 3,715 |
| Selling, general and administrative | 1,668 | 1,704 | 1,893 | 1,760 |
| Research and development | - | 471 | 528 | 469 |
| Acquired in-process research and development and milestones | - | - | 8 | 81 |
| Restructuring costs | 3 | 28 | 62 | 31 |
| Interest expense | - | 422 | 527 | 520 |
| Exchange losses | -18 | -11 | -42 | -26 |
| Other expense, net | -279 | -15 | -15 | -21 |
| Income before income taxes | 1,529 | 1,122 | 673 | 807 |
| Income tax (benefit) expense | 178 | 205 | -350 | -57 |
| Net income | 1,351 | 917 | 1,023 | 864 |
| Earnings Per Share, Basic | 5.33 | 3.61 | 4.01 | 3.36 |
| Earnings Per Share, Diluted | 5.31 | 3.59 | 3.99 | 3.33 |